Back to discover

Protein / target

Phospholipid hydroperoxide glutathione peroxidase GPX4

Encoded byGPX4P36969Homo sapiensSwiss-Prot
Small-molecule tractable
Druggability
Structure with Ligand
5
Research papers

Protein at a glance

Biological role

Phospholipid-hydroperoxide glutathione peroxidase

Strongest disease association

Nasal Polyps

Via encoding gene GPX4 · Genetic evidence · score 0.49

Research activity

Emerging research

5 papers · latest 2026

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Essential antioxidant peroxidase that directly reduces phospholipid hydroperoxide even if they are incorporated in membranes and lipoproteins.

View complete UniProt function annotation

Essential antioxidant peroxidase that directly reduces phospholipid hydroperoxide even if they are incorporated in membranes and lipoproteins (PubMed:40281343). Can also reduce cholesterol hydroperoxide and thymine hydroperoxide (By similarity). Plays a key role in protecting cells from oxidative damage by preventing membrane lipid peroxidation (PubMed:40281343). Required to prevent cells from ferroptosis, a non-apoptotic cell death resulting from an iron-dependent accumulation of lipid reactive oxygen species (PubMed:24439385, PubMed:40281343). The presence of selenocysteine (Sec) versus Cys at the active site is essential for life: it provides resistance to overoxidation and prevents cells against ferroptosis (By similarity). The presence of Sec at the active site is also essential for the survival of a specific type of parvalbumin-positive interneurons, thereby preventing against fatal epileptic seizures (By similarity). May be required to protect cells from the toxicity of ingested lipid hydroperoxides (By similarity). Required for normal sperm development and male fertility (By similarity). Essential for maturation and survival of photoreceptor cells (By similarity). Plays a role in a primary T-cell response to viral and parasitic infection by protecting T-cells from ferroptosis and by supporting T-cell expansion (By similarity). Plays a role of glutathione peroxidase in platelets in the arachidonic acid metabolism (PubMed:11115402). Reduces hydroperoxy ester lipids formed by a 15-lipoxygenase that may play a role as down-regulator of the cellular 15-lipoxygenase pathway (By similarity). Can reduce fatty acid-derived hydroperoxides (PubMed:11115402, PubMed:36608588). Can also reduce small soluble hydroperoxides such as H2O2, cumene hydroperoxide and tert-butyl hydroperoxide (PubMed:17630701, PubMed:36608588)

Subcellular location

MitochondrionCytoplasm
Domains and Gene Ontology detail (20)

Gene Ontology

  • Ccytosol
  • Cextracellular exosome
  • Cmitochondrion
  • Cnuclear envelope
  • Cnucleus
  • Cprotein-containing complex
  • Fglutathione peroxidase activity
  • Fidentical protein binding
  • Fphospholipid-hydroperoxide glutathione peroxidase activity
  • Fselenium binding
  • Parachidonate metabolic process
  • Pcellular response to oxidative stress

197 aa · 22 kDa · 2 isoforms

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Lipid & lipoprotein metabolismUniProt · GO
View supporting evidence

Lipid & lipoprotein metabolism

  • ·Essential antioxidant peroxidase that directly reduces phospholipid hydroperoxide even i…
  • ·phospholipid-hydroperoxide glutathione peroxidase activity
  • ·long-chain fatty acid biosynthetic process
  • ·phospholipid metabolic process

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene GPX4

Gene-level evidence surfaced through the gene GPX4that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Nasal Polyps
0.49Limited support

Genetic evidence dominant · Open Targets 0.30

Basal cell carcinoma
0.46Limited support

Genetic evidence dominant · Open Targets 0.28

Skin Neoplasms
0.43Limited support

Genetic evidence dominant · Open Targets 0.26

Hypothyroidism
0.36Limited support

Genetic evidence dominant · Open Targets 0.22

Genetic Diseases, Inborn
0.33Limited support

Genetic evidence dominant · Open Targets 0.20

View evidence synthesis (5)
Nasal PolypsLimited support
0.49
agreement 0.350.63
Genetic99%Literature1%

Open Targets aggregate 0.30 · 2 independent evidence families

Basal cell carcinomaLimited support
0.46
agreement 0.340.58
Genetic100%

Open Targets aggregate 0.28 · 1 independent evidence family

Skin NeoplasmsLimited support
0.43
agreement 0.290.57
Genetic99%Literature1%

Open Targets aggregate 0.26 · 2 independent evidence families

HypothyroidismLimited support
0.36
agreement 0.230.50
Genetic97%Literature3%

Open Targets aggregate 0.22 · 2 independent evidence families

Genetic Diseases, InbornLimited support
0.33
agreement 0.190.46
Genetic96%Literature4%

Open Targets aggregate 0.20 · 2 independent evidence families

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Neurodegenerative Diseases0.47
Nasal Polyps0.30
Basal cell carcinoma0.28
Skin Neoplasms0.26
Hypothyroidism0.22
Genetic Diseases, Inborn0.20
Hemolysis0.18

Tractability

Small moleculesEmerging

Feasibility evidence (structure with ligand and high-quality ligand) — no clinical-stage drug of this modality recorded.

Protein degradersEmerging

Feasibility evidence (database ubiquitination and half-life data) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (5)
SM · Structure with LigandSM · High-Quality LigandPR · Database UbiquitinationPR · Half-life DataPR · Small Molecule Binder

Raw Open Targets tractability assessment buckets, by modality.

Research activity

5 papers · to 2026

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Reichert CO · International journal of molecular sciences · 2020

Lei P · The Journal of biological chemistry · 2021

Xuan Y · Oxidative medicine and cellular longevity · 2022

Recent

Europe PMC papers linked directly to this protein.

Related family literature

1

Papers about “selenoproteins” — a broader family this protein belongs to. Shown as context; not counted as papers specifically about this protein.

Europe PMC literature, reached through curated HGNC family membership. Membership is a taxonomic relationship — it does not imply this protein participates in every mechanism these papers discuss.